Sign in

CIK 0001754068

  • Non-accelerated filer
  • Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831971007
Phone
+1 650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-04 Miller Edward General Counsel Sale −424 $0.64 $271 235,534
2024-01-04 Brainard Diana Chief Executive Officer Sale −1,664 $0.64 $1K 873,242
2024-01-04 Hagen Brett R Chief Accounting Officer Sale −310 $0.64 $198 97,190
2023-12-27 Hagen Brett R Chief Accounting Officer Sale −28,335 $0.74 $21K 97,500
2023-11-20 Brainard Diana Chief Executive Officer Sale 10b5-1 −4,382 $1.69 $7K 874,906
2023-11-17 Hagen Brett R Chief Accounting Officer Sale 10b5-1 −403 $1.63 $657 125,835
2023-11-17 Sinha Vikas See Remarks Sale 10b5-1 −2,490 $1.63 $4K 1,167,749
2023-11-17 Brainard Diana Chief Executive Officer Sale 10b5-1 −2,689 $1.63 $4K 879,288
2023-10-20 Sinha Vikas See Remarks Sale 10b5-1 −1,475 $1.54 $2K 1,170,239
2023-10-20 Hagen Brett R Chief Accounting Officer Sale 10b5-1 −357 $1.54 $550 126,238
2023-10-19 Brainard Diana Chief Executive Officer Sale 10b5-1 −8,581 $1.58 $14K 881,977
2023-10-19 Sinha Vikas See Remarks Sale 10b5-1 −1,232 $1.58 $2K 1,171,714
2023-10-19 Hagen Brett R Chief Accounting Officer Sale 10b5-1 −358 $1.58 $566 126,595
2023-10-03 Brainard Diana Chief Executive Officer Sale 10b5-1 −1,325 $1.98 $3K 890,558
2023-10-03 Sinha Vikas See Remarks Sale 10b5-1 −755 $1.98 $1K 1,172,946
2023-10-03 Hagen Brett R Chief Accounting Officer Sale 10b5-1 −222 $1.98 $439 126,953
2023-08-18 Brainard Diana Chief Executive Officer Sale 10b5-1 −4,055 $2.79 $11K 891,883
2023-08-17 Sinha Vikas See Remarks Sale 10b5-1 −10,516 $2.50 $26K 1,173,701
2023-08-17 Brainard Diana Chief Executive Officer Sale 10b5-1 −11,361 $2.50 $28K 895,938
2023-08-17 Hagen Brett R Chief Accounting Officer Sale 10b5-1 −1,653 $2.50 $4K 127,175

Page 8 of 13 · 259 trades